IQVIA Financial Statements From 2010 to 2025
QTS Stock | EUR 169.25 2.90 1.74% |
Check IQVIA Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IQVIA Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . IQVIA financial statements analysis is a perfect complement when working with IQVIA Holdings Valuation or Volatility modules.
IQVIA |
IQVIA Holdings Company Return On Equity Analysis
IQVIA Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current IQVIA Holdings Return On Equity | 0.18 |
Most of IQVIA Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IQVIA Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, IQVIA Holdings has a Return On Equity of 0.1848. This is 100.77% lower than that of the Healthcare sector and 102.77% lower than that of the Diagnostics & Research industry. The return on equity for all Germany stocks is 159.61% lower than that of the firm.
IQVIA Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IQVIA Holdings's current stock value. Our valuation model uses many indicators to compare IQVIA Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IQVIA Holdings competition to find correlations between indicators driving IQVIA Holdings's intrinsic value. More Info.IQVIA Holdings is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for IQVIA Holdings is roughly 3.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IQVIA Holdings' earnings, one of the primary drivers of an investment's value.About IQVIA Holdings Financial Statements
IQVIA Holdings stakeholders use historical fundamental indicators, such as IQVIA Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although IQVIA Holdings investors may analyze each financial statement separately, they are all interrelated. For example, changes in IQVIA Holdings' assets and liabilities are reflected in the revenues and expenses on IQVIA Holdings' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IQVIA Holdings. Please read more on our technical analysis and fundamental analysis pages.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina. IQVIA HLDGS operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 61000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in IQVIA Stock
When determining whether IQVIA Holdings is a strong investment it is important to analyze IQVIA Holdings' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact IQVIA Holdings' future performance. For an informed investment choice regarding IQVIA Stock, refer to the following important reports:Check out the analysis of IQVIA Holdings Correlation against competitors. For more detail on how to invest in IQVIA Stock please use our How to Invest in IQVIA Holdings guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.